Skip to main content

Listen

Read

Watch

Schedules

Programs

Events

Give

Account

Donation Heart Ribbon

SPECIAL COVERAGE: Living With Wildfires: San Diego Firestorm 10 Years Later

Company Hopes Its Pain Rub Will Compete With Pills

Audio

The San Diego biotech says phase-three trials of its topical pain rub show it could be a safer alternative to pain pills like Tylenol and ibuprofen.

— The San Diego biotech says phase-three trials of its topical pain rub show it could be a safer alternative to pain pills like Tylenol and ibuprofen.

The pain rub, called Ketotransdel, is made by Transdel Pharmaceuticals. Trial results showed the rub worked better than a placebo when patients rated their pain before and after treatment. Ketotransdel is a cream that's applied to the skin to treat pain from injuries like sprained ankles and pulled muscles. Its active ingredient is ketoprofen, a chemical cousin of ibuprofen, which is absorbed by the muscles. Transdel's CEO is Juliet Singh. She says her pain rub is safer than pain pills, which can cause liver damage and stomach problems, because it creates lower drug concentrations in the patient's blood system. Ketotransdel did fall short on one testing guideline during clinical trials, though company officials blamed that on poor test protocols. Singh says her company will seek FDA approval for its topical pain rub.

Want more KPBS news?
Find us on Twitter and Facebook, or subscribe to our newsletters.

To view PDF documents, Download Acrobat Reader.